New injection therapy targets Hard-to-Treat cancers
NCT ID NCT05427487
First seen Mar 30, 2026 · Last updated May 08, 2026 · Updated 8 times
Summary
This early-stage trial tests an experimental drug called IVX037, injected directly into tumors, for people with advanced colorectal, gastric, or ovarian cancers that have stopped responding to standard treatments. The study has two parts: first, testing IVX037 alone to find a safe dose, and second, combining it with an immunotherapy drug (sintilimab) to see if the combination is safe and effective. About 70 participants will be enrolled to evaluate side effects and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Melbourne Site
RECRUITINGMelbourne, Victoria, 3000, Australia
Contact
-
South Australia site
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact
-
Sydney site
RECRUITINGSydney, New South Wales, 2000, Australia
Contact
Conditions
Explore the condition pages connected to this study.